¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"INT"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
  • JrId: 4303
    JournalTitle: planning, administration, evaluation.
    MedAbbr: Int J Health Serv
    ISSN: 0020-7314
    ESSN:
    IsoAbbr:
    NlmId: 1305035
  • JrId: 4304
    JournalTitle: International journal of sports medicine.
    MedAbbr: Int J Sports Med
    ISSN: 0172-4622
    ESSN:
    IsoAbbr:
    NlmId: 8008349
  • JrId: 4305
    JournalTitle: International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation.
    MedAbbr: Int J Rehabil Res
    ISSN: 0342-5282
    ESSN:
    IsoAbbr:
    NlmId: 7805421
  • JrId: 4306
    JournalTitle: International journal of cancer. Supplement = Journal international du cancer. Supplement.
    MedAbbr: Int J Cancer Suppl
    ISSN: 0898-6924
    ESSN:
    IsoAbbr: Int. J. Cancer Suppl.
    NlmId: 8710267
  • JrId: 4308
    JournalTitle: International journal of law and psychiatry.
    MedAbbr: Int J Law Psychiatry
    ISSN: 0160-2527
    ESSN:
    IsoAbbr:
    NlmId: 7806862
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • S06.7
    Intracranial injury with prolonged coma
    Áö¼ÓÀû È¥¼ö¸¦ µ¿¹ÝÇÑ ¸Ó¸®³» ¼Õ»ó
  • S06.9
    Intracranial injury, unspecified
    »ó¼¼ºÒ¸íÀÇ ¸Ó¸®³» ¼Õ»ó
  • P10
    Intracranial laceration and haemo- rrhage due to birth injury
    Ãâ»ê ¼Õ»óÀ¸·Î ÀÎÇÑ µÎ°³°­³» ¿­»ó ¹× ÃâÇ÷
  • P52
    Intracranial nontraumatic haemorrhage of fetus and newborn
    ÅÂ¾Æ ¹× ½Å»ý¾ÆÀÇ µÎ°³°­³» ºñ¿Ü»ó¼º ÃâÇ÷
  • R90.0
    Intracranial space-occupying lesion
    ¸Ó¸®³» °ø°£-Á¡À¯¼º º´ÅÍ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • internal bleeding
    ³»ÃâÇ÷
  • internal callus
    ¾ÈÂʾֹú»À, ³»°¡°ñ
  • internal capsule
    ¼Ó¼¶À¯¸·, ³»Æ÷
  • internal carotid artery
    ¼Ó¸ñµ¿¸Æ, ³»°æµ¿¸Æ
  • internal carotid nerve
    ¼Ó¸ñµ¿¸Æ½Å°æ, ³»°æµ¿¸Æ½Å°æ
  • internal carotid plexus
    ¼Ó¸ñµ¿¸Æ½Å°æ¾ó±â, ³»°æµ¿¸Æ½Å°æÃÑ
  • internal cerebral veins
    ¼Ó´ë³úÁ¤¸Æ, ³»´ë³úÁ¤¸Æ
  • internal compensation
    ºÐÀÚ³»º¸»ó
  • internal conjugate diameter
    ¼Ó¾ÕµÚÁö¸§, ³»°áÇÕ°æ
  • internal conversion
    ³»ºÎº¯È¯
  • internal decompression
    ³»°¨¾Ð(¼ú)
  • internal dosimetry
    ü³»¼±·®ÃøÁ¤(¹ý)
  • internal ear
    ¼Ó±Í, ³»ÀÌ
  • internal fecundation
    ü³»¼öÁ¤, ¸ö¾È¼öÁ¤
  • internal fistula
    ¼Ó»û±æ, ³»´©°ø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • internal carotid artery
    ¼Ó¸ñµ¿¸Æ
  • internal carotid nerve
    ¼Ó¸ñ½Å°æ
  • internal compensation
    ºÐÀÚ³»º¸»ó
  • internal conjugate diameter
    ¾ÈÂʾյÚÁö¸§, ³»°áÇÕ°æ
  • internal conversion
    ³»ºÎº¯È¯
  • internal decompression
    ³»°¨¾Ð¼ú
  • internal dosimetry
    ü³»¼±·®ÃøÁ¤
  • internal ear
    ¼Ó±Í, ³»ÀÌ
  • internal environment
    ³»ºÎȯ°æ
  • internal fecundation
    ü³»¼öÁ¤, ¸ö¾È¼öÁ¤
  • internal fistula
    ¼Ó»û±æ, ³»·ç
  • internal genu
    (¢¡genu valgum) ¿Ü¹Ý½½, ¾È±ÁÀ̹«¸­
  • internal hemorrhoid
    ¼ÓÄ¡Áú
  • internal hordeolum
    ¼Ó´Ù·¡³¢, ³»¸Æ¸³Á¾
  • internal image vaccine
    ³»ºÎ¿µ»ó¹é½Å, °³º°Æ¯ÀÌÇü¹é½Å
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • interfascicular fascicles
    ´Ù¹ß»çÀÌ´Ù¹ß
  • interference
    °£¼·
  • interference assay
    °£¼·ÃøÁ¤¹ý
  • interference filter
    °£¼·ÇÊÅÍ
  • interference method in cell culture
    ¼¼Æ÷¹è¾ç°£¼·¹ý
  • interference microscope
    °£¼·Çö¹Ì°æ
  • interference microscope
    °£¼·Çö¹Ì°æ.
  • interference of light
    ºûÀÇ °£¼·.
  • interference phenomenon
    °£¼·Çö»ó
  • interference phenomenon
    °£¼·Çö»ó(ÊÎàïúÞßÚ).
  • interference spectroscope
    °£¼·ºÐ±¤±â.
  • interference substance
    °£¼·¹°Áú.
  • interferential action
    °£¼·ÀÛ¿ë.
  • interferometer
    °£¼·°è
  • interferometry
    °£¼·¹ý(ÊÎàïÛö).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • Intervertebral surface
    ¸öÅë»çÀ̸é
    [¿¾ ¿ë¾î] Ãß°£¸é
  • Intervertebral symphysis
    ôÃß»çÀ̰áÇÕ
    [¿¾ ¿ë¾î] Ãß°£(¼¶À¯¿¬°ñ)°áÇÕ
  • Intervertebral vein
    ôÃß»çÀÌÁ¤¸Æ
    [¿¾ ¿ë¾î] Ãß°£Á¤¸Æ
  • Intervillous space
    À¶¸ð»çÀ̰ø°£
    [¿¾ ¿ë¾î] À¶¸ð°£±Ø
  • Intestinal gland [Crypt of Lieberkuhn]
    âÀÚ»ù [âÀÚ¿ò]
    [¿¾ ¿ë¾î] Àå¼±
  • Intestinal gland [Intestinal crypt]
    âÀÚ»ù [âÀÚ¿ò]
    [¿¾ ¿ë¾î] Àå¼±
  • Intestinal glands
    âÀÚ»ù [âÀÚ¿ò]
    [¿¾ ¿ë¾î] Àå¼±
  • Intestinal loop
    âÀÚ°í¸®
    [¿¾ ¿ë¾î] Àå°í¸®
  • Intestinal surface
    µÚ¸é
    [¿¾ ¿ë¾î] Èĸé
  • Intestinal trunk
    âÀÚ¸²ÇÁ°üÁÙ±â
    [¿¾ ¿ë¾î] ÀåÀÓÆÄº»°£
  • Intestinal villi
    âÀÚÀ¶¸ð
    [¿¾ ¿ë¾î] ÀåÀ¶¸ð
  • Intestinal villus
    âÀÚÀ¶¸ð
    [¿¾ ¿ë¾î] ÀåÀ¶¸ð
  • Intra-articular ligament of head of rib
    °üÀý¼Ó°¥ºñ»À¸Ó¸®Àδë
    [¿¾ ¿ë¾î] °üÀý³»´Á°ñµÎÀδë
  • Intra-articular sternocostal ligament
    °üÀý¼Óº¹Àå°¥ºñÀδë
    [¿¾ ¿ë¾î] °üÀý³»È两Àδë
  • Intra-articular structure
    °üÀý¼Ó±¸Á¶¹°
    [¿¾ ¿ë¾î] °üÀý³»±¸Á¶
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intimal flap
    ³»¸·Æí, ³»¸·ÆÇ
  • intoe
    ³»Á·Áö, ¹«Áö ¿Ü¹ÝÁõ
  • intoxicating dose
    Áßµ¶·®, Áßµ¶ ¼±·®
  • intoxication of phosphorus
    ÀÎ Áßµ¶
    ³ë¶õ Àο¡ ÀÇÇÑ Áßµ¶Áõ. ºÓÀº ÀÎÀº µ¶ÀÌ ¾øÀ¸³ª ³ë¶õ ÀÎÀº µ¶¼ºÀÌ ¸Å¿ì °­ÇÏ´Ù. °£È¤ ÀÚ»ì ¶Ç´Â Å¸»ìÀÇ ¸ñÀûÀ¸·Î »ç¿ëµÇ±âµµ ÇÑ´Ù. Àü¿¡´Â ³ë¶õ ÀÎ ¼º³ÉÀÇ Á¦Á¶ °øÀå µî¿¡¼­ ³ë¶õ ÀÎÀ» Ãë±ÞÇÏ´Â Á÷¾÷¼ºÀÇ ¸¸¼º Áßµ¶, ±Ù·¡¿¡´Â ³ó¾àÀÇ ÆÄ¶óƼ¿Â Áßµ¶À¸·Î¼­ ¹®Á¦°¡ µÈ ÀûÀÌ ÀÖ´Ù. ±Þ¼º Áßµ¶ÀÏ ¶§´Â ½ÉÇÑ ±¸Åä, Ç÷¾×ÀÌ ¼¯ÀÎ ¼³»ç, Ç÷¾Ð °­ÇÏ, È£Èí °ï¶õÀ» ÀÏÀ¸Å°°í, ÇãÅ» »óÅ¿¡ ºüÁ®¼­ ¼ö ½Ã°£ÀÌ¸é »ç¸ÁÇÑ´Ù. ´ë°³´Â ¾Æ±Þ¼º À§Àå Áõ¼¼·ÎºÎÅÍ ½ÃÀ۵ȴÙ. °£ÀÌ Ä§ÇØµÇ¾î ±â´ÉºÎÀü¿¡ ºüÁö°í Ȳ´ÞÀÌ ÇöÀúÇÏ°Ô ³ªÅ¸³ª¸ç, À§Àå Áõ¼¼µµ Á¡Â÷·Î ½ÉÇØÁü°ú µ¿½Ã¿¡ ÃâÇ÷ °æÇâÀÌ Áõ´ëÇϰí, ¸»±â¿¡´Â È¥¼ö »óŰ¡ µÇ¾î ½ÉÀå ¼è¾àÀ¸·Î ÀÎÇÏ¿© »ç¸ÁÇÑ´Ù. Åä¹°Àº ¸¶´Ã ³¿»õ¿Í °°Àº ƯÀÌÇÑ ³¿»õ°¡ ³ª°í, ½Àµµ°¡ ³ôÀº °ø±â ¼Ó¿¡¼­´Â Àο¬À̶ó°í ÇÏ´Â Èò ¿¬±â°¡ º¸À̸ç, ¾îµÎ¿î °÷¿¡¼­´Â Àα¤À» ¹ßÇÑ´Ù. º¹¿ë Á÷ÈÄÀÏ ¶§´Â °ú¸Á°£»ê Ä®·ý, Ȳ»ê ±¸¸® ¾×, °ú»êÈ­ ¼ö¼Ò ¼ö µîÀÇ »êÈ­Á¦·Î À§ ¼¼Ã´À» ÇÑ´Ù. ÇǸ¶ÀÚÀ¯ µîÀÇ À¯·ù³ª ¿ìÀ¯, ´Þ°¿ µî Áö¹æºÐÀ» ¸¹ÀÌ ÇÔÀ¯ÇÏ´Â °ÍÀº ÀÎÀÇ Èí¼ö¸¦ ÃËÁø½ÃŰ¹Ç·Î Àý´ë·Î ¸Ô¿©¼­´Â ¾È µÈ´Ù. ÆÄ¶óƼ¿Â¿¡ ÀÇÇÑ °æ¿ì´Â ´Ù½Ã Ç×Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦ ÀÛ¿ë¿¡ ÀÇÇÑ Áõ¼¼°¡ ³ªÅ¸³­´Ù. Áï, µ¿°øÀÌ ¼öÃàÇϰí, ¹ßÇÑ, ±â°üÁö ºÐºñ Ç×Áø, ¼³»ç, Ç÷¾Ð »ó½Â, ¹ß¿­ µîÀÌ ÀÖÀ¸¸ç, ÁßÁõÀÎ °æ¿ì¿¡´Â È£Èí±Ù ¸¶ºñ³ª ½É½Ç ¼¼µ¿À» ÀÏÀ¸ÄÑ »ç¸ÁÇÑ´Ù. Ä¡·á´Â ¾ÆÆ®·ÎÇÉÀÇ ´ë·® Åõ¿©³ª PAMÀÇ ÁÖ»ç, Àΰø È£ÈíÀ̳ª ¼ö¾× µîÀ» ÇàÇÑ´Ù. ¶Ç ¿¹¹æÀ¸·Î¼­´Â ÆÄ¶óƼ¿ÂÁ¦ÀÇ Ãë±ÞÀÚ´Â ÀÚÁÖ Ç÷û Äݸ° ¿¡½ºÅ×¶ó¾ÆÁ¦ °ªÀ» ÃøÁ¤ÇÏ¿© Áßµ¶¿¡ ºüÁö´Â °ÍÀ» ¸·´Â´Ù.
  • intra-abdominal pressure
    º¹°­ ³»¾Ð
    º¹°­³» ³»Àå°£ÀÇ ¾Ð·Â.
  • intra-arch discrepancy
    ¾Ç±Ã³» ºÎÁ¶È­
  • intra-arterial
    µ¿¸Æ³»ÀÇ
  • intra-arterial injection
    µ¿¸Æ³» ÁÖ»ç
  • intra-articular
    °üÀý³»
    °üÀý³»¿¡ À§Ä¡ÇÏ´Â.
  • intra-extraoral appliance
    ±¸°­³»¿Ü ÀåÄ¡
  • intra-osseous anesthesia
    °ñ³» ¸¶Ãë
  • intra-voxel dephasing
    º¹¼¿³» À§»ó ºÐ»ê
  • intraabdominal approach
    º¹°­³» µµ´Þ¹ý
  • intraarch tooth alignment
    ¾Ç±Ã³» Ä¡¾Æ ¹è¿­, Ä¡±Ã³» Ä¡¾Æ ¹è¿­
  • intraarticular injection
    °üÀý³» ÁÖ»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
interference dissociation The simultaneous operation of two separate cardiac pacemaking foci that are unassociated because of interference (a normal physiologic phenomenon) due to rendering their respective territories refractory to each other. Usually atrioventricular dissociation is indicated, the rates being quite close to each other with the atrial rate slightly faster than that of the pacemaker in control of the ventricles. Capture is in either direction, usually the ventricle by the atrium, in incomplete dissociation. H
Synonym: dissociation by interference.
(05 Mar 2000)
interference figure <microscopy> The conoscopic pattern of extinction positions of a crystal superimposed on the pattern of interference colours corresponding to the full cone of directions by which the crystal is illuminated, each direction showing its own interference colour.
(05 Aug 1998)
interference microscope <instrument> A specially constructed microscope in which the entering light is split into two beams which pass through the specimen and are recombined in the image plane where the interference effects make the transparent (invisible) refractile object details become visible as intensity differences; permits measurements of light retardation, index of refraction, and thickness and mass of specimen; it is useful in the examination of living or unstained cells.
(05 Mar 2000)
interference microscopy <procedure> Although all image formation depends on interference, the term is generally restricted to systems in which contrast comes from the recombination of a reference beam with light that has been retarded by passing through the object. Because the phase retardation is a consequence of the difference in refractive index between specimen and medium and because the the refractive increment is almost the same for all biological molecules, it is possible to measure the amount of dry mass per unit area of the specimen by measuring the phase retardation. Quantification of the phase retardation is usually done by using a compensator to reduce the bright object to darkness (see Senarmont and Ehrlinghaus compensators). Two major optical systems have been used the Jamin Lebedeff system and the Mach Zehnder system. These instruments are often referred to as interferometers, since they are designed for measuring phase retardation. Although their use has passed out of fashion, it may be that they will be employed more frequently in future in conjunction with image analysing systems.
(18 Nov 1997)
interference reflection microscopy <procedure> An optical technique for detecting the topography of the side of a cell in contact with a planar substrate and for providing information on the separation of the plasmalemma from the substrate. Interference between the reflections from the substrate medium interface and the reflections from the plasmalemma medium interface generate the image.
(18 Nov 1997)
interferometer <radiobiology> Device which measures changes in a medium by looking at effects on the interference of two waves which are passed through that medium.
See: interferometry, laser interferometer, optical inteferometer, Fabry-Perot interferometer, microwave interferometer.
(09 Oct 1997)
interferometry <radiobiology> Method of gathering information about a medium by using an interferometer or similar technique.
Optical - Uses light as the wave to be interfered.
Microwave - Uses microwaves instead. Microwave interferometry is especially useful in plasma physics for measuring plasma densities.
(09 Oct 1997)
interferon <cytokine> A family of glycoproteins derived from human cells which normally has a role in fighting viral infections by preventing virus multiplication in cells.
They are secreted by vertebrate cells in response to a wide variety of inducers and confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions.
Interferon-alpha is made by leucocytes and interferon-gamma by fibroblasts after viral infection. Interferon-alpha and -beta are also called type I interferons, interferon-gamma as Type II interferons, more usually classed as cytokines.
Pharmacological action: antineoplastic agent, antiviral agents.
(20 Sep 2002)
interferon inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers poly a-u and poly I-c. Viruses, bacteria, and protozoa have been also known to induce interferons.
(12 Dec 1998)
interferon type I <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta).
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
interferon type II <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced)
(12 Dec 1998)
interferon-alpha <cytokine> One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products.
It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, causes activation of NK cells. It is used experimentally in the treatment of hairy-cell leukaemia.
A number of different subtypes exist that are elaborated by leukocytes in response to viral infection or stimulation with double-stranded RNA; IFN-alpha-2A and -2B are protein products made by recombinant DNA techniques and are used as antineoplastic agents.
See: interferon-alpha 2a, interferon-alpha 2b
Synonym: leukocyte interferon.
Pharmacological action: antineoplastic agent, antiviral agent.
(20 Sep 2002)
interferon-alpha 2a <cytokine> Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-alphaA (human leukocyte protein moiety reduced)
(12 Dec 1998)
interferon-alpha 2b <chemical> Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
interferon-b2 <cytokine> A cytokine that stimulates the growth and differentiation of human B-cells and is also a growth factor for hybridomas and plasmacytomas.
It is produced by many different cells including T-cells, monocytes, and fibroblasts. A single chain 25 kD cytokine originally described as a pre B-cell growth factor, now known to have effects on a number of other cells including T-cells which are also stimulated to proliferate.
An inducer of acute phase proteins and a colony-stimulating factor acting on mouse bone marrow.
Acronym: IL-6
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 17
  • Interleukin-12 Receptor beta 2 Subunit - »õâ A subunit of the interleukin-12 receptor. It plays a role in receptor signaling by associating with JANUS KINASE 2.
    Synonyms : Interleukin-12 Receptor beta 2 Chain, Interleukin-12 Receptor p35 Subunit, Interleukin 12 Receptor beta 2 Chain, Interleukin 12 Receptor beta 2 Subunit, Interleukin 12 Receptor p35 Subunit
  • Interleukin-12 Subunit p35 - »õâ A subunit of interleukin-12. It binds to the INTERLEUKIN-12 SUBUNIT P40 via a disulfide bond that results in the active cytokine.
    Synonyms : IL-12p35, Interleukin 12a, Interleukin-12 p35, Interleukin 12 Subunit p35, Interleukin 12 p35, Subunit p35, Interleukin-12
  • Interleukin-12 Subunit p40 - »õâ A cytokine subunit that is a component of both interleukin-12 and interleukin-23. It binds to the INTERLEUKIN-12 SUBUNIT P35 via a disulfide bond to form interleukin-12 and to INTERLEUKIN-23 SUBUNIT P19 to form interleukin-23.
    Synonyms : IL-12p40, Interleukin-12 beta Chain, Interleukin-12, 23 p40 Subunit, Interleukin-12b, Interleukin-23 Subunit p40, Chain, Interleukin-12 beta, Interleukin 12 Subunit p40, Interleukin 12 beta Chain, Interleukin 12, 23 p40 Subunit, Interleukin 12b
  • Interleukin-13 - »õâ A cytokine synthesized by T-LYMPHOCYTES that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-LYMPHOCYTES. It appears to play a role in regulating inflammatory and immune responses.
    Synonyms : IL 13, IL13, Interleukin 13
  • Interleukin-13 Receptor alpha1 Subunit - »õâ An interleukin receptor subunit with specificity for INTERLEUKIN-13. It dimerizes with the INTERLEUKIN-4 RECEPTOR ALPHA SUBUNIT to form the TYPE II INTERLEUKIN-4 RECEPTOR which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13. Signaling of this receptor subunit occurs through the interaction of its cytoplasmic domain with JANUS KINASES such as the TYK2 KINASE.
    Synonyms : CD213a1 Antigen, IL-13Ralpha1, Interleukin-13 Receptor alpha1 Chain, Antigen, CD213a1, Antigens, CD213a1, CD213a1, Antigens, Interleukin 13 Receptor alpha1 Chain, Interleukin 13 Receptor alpha1 Subunit, Interleukin 4, 13 Receptor Shared Subunit
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
intracellular located or occurring within a cell or cells; "intracellular fluid"
Ãâó: wordnet.princeton.edu/perl/webwn
intermittent tetanus tetany: clinical neurological syndrome characterized by muscular twitching and cramps and (when severe) seizures; associated with calcium deficiency (hypoparathyroidism) or vitamin D deficiency or alkalosis
Ãâó: wordnet.princeton.edu/perl/webwn
internal auditory artery labyrinthine artery: a branch of the basilar artery that supplies the labyrinth
Ãâó: wordnet.princeton.edu/perl/webwn
intelligence quotient a measure of a person's intelligence as indicated by an intelligence test; the ratio of a person's mental age to their chronological age (multiplied by 100)
Ãâó: wordnet.princeton.edu/perl/webwn
internal auditory vein labyrinthine vein: veins that drain the inner ear
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • interdict
    ±ÝÁö(Á¦Áö)ÇÏ´Ù;¹æÇØÇÏ´Ù;(õÁÖ±³)¼ºÁ÷(¼º¹«)À» Á¤Áö½ÃŰ´Ù;(¹Ì)(Æø°ÝµîÀ¸·Î)¼ö¼ÛÀ» ¹æÇØÇÏ´Ù;±ÝÁö(¸í·É);±ÝÁ¦;(õÁÖ±³)ÆÄ¹®;¼ºÁ÷Á¤Áö
  • interdiction
    ±ÝÁö
  • interdiction
    ±ÝÁö;±ÝÁ¦;Á¤Áö¸í·É;(¹ý)±ÝÄ¡»ê¼±°í;Åë»ó±ÝÁö;(±º)ÀúÁö(±º»çÇൿÀ» ÀúÁöÇϱâ À§ÇÑ Æø°Ý,Æ÷°Ý)
  • interdictory
    ±ÝÁöÀÇ;±ÝÁ¦ÀÇ
  • interdigitate
    ±ïÁö³¢´Ù;¼­·Î ¸Â¹°(¸®°Ô ÇÏ)´Ù;¼­·Î ¾ôÈ÷(°ÔÇÏ)´Ù
  • interdisciplinary
    µÑÀÌ»óÀÇ Çй®ÀÌ °ü¿©(Á¦ÈÞ,ÀÌ¿ë,°øÇå)ÇÏ´Â ÀÌºÐ¾ß Á¦ÈÞÀÇ;¿©·¯ºÐ¾ß¿¡ °ÉÄ¡´Â;ÇÐÁ¦ÀûÀÎ
  • interdit
    ±ÝÁöµÈ(prohibited)
  • interest
    Èï¹Ì,ÀÌÀÍ,Èï¹Ì¸¦ ÀÏÀ¸Å°´Ù
  • interest
    Èï¹Ì;°ü½É;°¨Èï;Àç¹Ì;È£±â½É;°ü½É»ç;Ãë¹Ì;Á߿伺;ÀÌÇØ°ü°è;ÀÌÀͰü°è;¹°±Ç;À̱Ç;±ÇÀÍ;(°¡Áø)ÁÖ;ÀÌÀÍ;ÀÌ;µæ;»ç¸®;»ç½É;»ç¿å;¼¼·Â;½Å¿ë;(°°Àº ÀÌÇØ°ü°èÀÇ)µ¿¾÷ÀÚµé;ÁÖÀåÀ» °°ÀÌÇÏ´Â »ç¶÷µé;ÀÌÀÚ;Èï¹Ì¸¦ ÀÏÀ¸Å©°ÔÇÏ´Ù;°ü½ÉÀ» °®°ÔÇÏ´Ù;°ü°è(°¡ÀÔ)½ÃŰ´Ù;°ü¿©ÇÏ°Ô ÇÏ´Ù;²ø¾î³Ö´Ù
  • interest rate
    ±Ý¸®ÀÌÀ²
  • interested
    Èï¹Ì¸¦ °¡Áø
  • interested
    Èï¹Ì¸¦ °¡Áø;ÀÌÇØ °ü°è ÀÖ´Â;ÀÌÇØ °ü°è°¡ ÀÖ´Â;Ÿ»êÀûÀÎ;»ç½ÉÀÌ ÀÖ´Â
  • interested group
    (»çȸ)ÀÌÀͰøµ¿Ã¼;°øÅëÀÌÇØ´Üü(±¹°¡ Á¤´çŬ·´µî)
  • interestedly
  • interesting
    Èï¹ÌÀÖ´Â
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 17
INT capable of replacing or changing places with something else
INT (mathematics, logic) such that the arguments or roles can be interchanged
INT the quality of being capable of exchange or interchange
INT in an interchangeable manner
INT occurring between or among or common to different churches or denominations
INT used of competition between colleges or universities
INT a communication system linking different rooms within a building or ship etc
INT the loudspeaker on an inter-com or public address system
INT transmit thoughts or feelings
INT be interconnected, afford passage
INT mutual communication
INT a communication system linking different rooms within a building or ship etc
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 17
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á